CN Stock MarketDetailed Quotes

GuangYuYuan Chinese Herbal Medicine (600771)

Watchlist
  • 16.22
  • +0.13+0.81%
Market Closed May 14 15:00 CST
7.94BMarket Cap120.15P/E (TTM)

GuangYuYuan Chinese Herbal Medicine (600771) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
17.04%488.22M
12.11%1.37B
18.71%1.06B
18.14%779.28M
21.48%417.14M
-4.87%1.22B
-7.93%893.53M
-4.90%659.6M
-11.13%343.38M
13.56%1.28B
Operating revenue
17.04%488.22M
12.11%1.37B
18.71%1.06B
18.14%779.28M
21.48%417.14M
-4.87%1.22B
-7.93%893.53M
-4.90%659.6M
-11.13%343.38M
13.56%1.28B
Other operating revenue
----
25.40%1.52M
----
71.75%441.91K
----
-9.56%1.21M
----
-95.40%257.29K
----
-90.76%1.34M
Total operating cost
17.93%413.67M
17.46%1.25B
17.48%935.48M
28.14%689.99M
24.73%350.78M
-8.77%1.06B
-8.58%796.3M
-13.79%538.46M
-20.19%281.23M
-12.22%1.16B
Operating cost
14.92%156.79M
37.71%443.7M
46.83%341.4M
50.90%247.98M
64.61%136.43M
-7.26%322.2M
-10.02%232.52M
-12.21%164.34M
-19.95%82.88M
-5.39%347.42M
Operating tax surcharges
35.13%12.05M
11.85%32.47M
39.30%25.08M
47.98%18.32M
11.36%8.92M
-8.33%29.03M
-32.51%18.01M
-41.87%12.38M
15.17%8.01M
54.12%31.67M
Operating expense
22.32%210.83M
10.21%638.4M
6.76%474.15M
22.26%361.14M
8.65%172.36M
-9.97%579.28M
-9.53%444.14M
-16.03%295.39M
-24.72%158.63M
-18.84%643.46M
Administration expense
16.59%23.48M
4.93%90.8M
-8.42%62.67M
-7.25%40.84M
-0.22%20.14M
-6.75%86.54M
15.01%68.44M
10.16%44.03M
9.59%20.19M
3.91%92.81M
Financial expense
-33.87%397.13K
-64.42%1.7M
-78.50%1.14M
-77.25%998.12K
-76.36%600.56K
-69.38%4.77M
-52.40%5.28M
-47.10%4.39M
-36.20%2.54M
-38.18%15.57M
-Interest expense (Financial expense)
-23.22%541.89K
-60.82%2.52M
-73.16%1.79M
-74.51%1.44M
-69.85%705.75K
-62.02%6.43M
-40.00%6.67M
-30.91%5.64M
-41.72%2.34M
-19.14%16.94M
-Interest Income (Financial expense)
-22.46%-225.9K
34.27%-1.16M
41.44%-911.12K
55.24%-587.8K
75.28%-184.47K
-16.78%-1.77M
-76.08%-1.56M
-345.83%-1.31M
-485.93%-746.32K
-56.69%-1.52M
Research and development
-18.02%10.11M
-0.33%38.47M
11.22%31.04M
15.50%20.72M
37.31%12.34M
22.98%38.59M
14.26%27.91M
11.99%17.94M
2.41%8.98M
8.36%31.38M
Credit Impairment Loss
----
100.13%91.95K
17.70%-12.97M
76.13%-12.97M
5,334.62%32.61K
-179.90%-70.01M
-102.55%-15.76M
-597.51%-54.33M
--600
-4.75%-25.01M
Asset Impairment Loss
----
-104.68%-24.9M
588,355.25%156.88K
--156.88K
----
-288.29%-12.16M
--26.66
----
----
94.52%-3.13M
Other net revenue
270.28%339.83K
80.58%-13.64M
-267.70%-303.08K
96.27%-1.5M
-332.92%-199.57K
-918.05%-70.22M
97.40%-82.43K
-1,057.11%-40.17M
-84.74%85.68K
91.39%-6.9M
Invest income
74.60%-93.46K
70.75%-2.26M
156.69%482.73K
95.87%-40.76K
57.83%-368.01K
-632.31%-7.73M
-844.57%-851.47K
-1,002.28%-986.5K
-2,759.47%-872.7K
258.01%1.45M
-Including: Investment income associates
----
77.40%-1.43M
251.17%1.29M
177.41%763.64K
111.46%100K
-536.69%-6.34M
-844.57%-851.47K
-1,002.28%-986.5K
-2,759.47%-872.7K
258.01%1.45M
Asset deal income
----
----
----
----
----
-110.69%-21.47K
-110.69%-21.47K
----
----
1,128.13%200.89K
Other revenue
218.98%433.29K
-31.86%13.43M
-27.33%12.02M
-25.04%11.35M
-85.82%135.84K
0.56%19.71M
285.16%16.55M
277.97%15.15M
144.18%957.78K
913.60%19.6M
Operating profit
13.20%74.89M
21.28%110.12M
28.61%124.94M
8.43%87.79M
6.31%66.16M
-20.91%90.8M
0.94%97.15M
23.56%80.97M
80.00%62.23M
142.00%114.81M
Add:Non operating Income
1,474.38%23.7K
-65.24%1.22M
-89.89%61.17K
649.87%58.66K
275.01%1.51K
1,976.20%3.51M
-95.43%605.29K
-92.46%7.82K
-99.60%401.34
-98.02%169.04K
Less:Non operating expense
-70.54%30.61K
-38.31%8.31M
-14.65%6.93M
-84.92%1.22M
-98.72%103.92K
-7.83%13.46M
55.74%8.12M
55.74%8.12M
1,199.53%8.1M
4,820.53%14.61M
Total profit
13.36%74.88M
27.45%103.04M
31.73%118.07M
18.90%86.63M
22.03%66.06M
-19.45%80.85M
-14.03%89.63M
20.58%72.86M
58.98%54.13M
137.86%100.37M
Less:Income tax cost
1,164.34%5.42M
1,528.80%39.35M
286.03%35.91M
64.65%7.04M
-90.49%429.07K
-136.61%-2.75M
-12.63%9.3M
-41.57%4.28M
-23.43%4.51M
453.69%7.52M
Add:Adjusted items effecting net profit
----
----
----
----
----
----
----
--0.01
----
----
Net profit
5.84%69.46M
-23.82%63.69M
2.27%82.15M
16.05%79.59M
32.25%65.63M
-9.96%83.6M
-14.19%80.33M
29.15%68.58M
76.21%49.62M
135.30%92.85M
Net profit from continuing operation
5.84%69.46M
-23.82%63.69M
2.27%82.15M
16.05%79.59M
32.25%65.63M
-9.96%83.6M
-14.19%80.33M
29.15%68.58M
76.21%49.62M
135.30%92.85M
Less:Minority Profit
33.12%2.72M
-92.94%646.07K
-65.07%3.27M
-69.61%2.73M
-75.44%2.04M
229.94%9.15M
353.67%9.36M
1,177.32%8.98M
1,405.66%8.32M
121.35%2.77M
Net profit of parent company owners
4.96%66.74M
-15.32%63.04M
11.16%78.88M
28.95%76.86M
53.94%63.58M
-17.35%74.45M
-22.49%70.96M
13.75%59.6M
49.61%41.3M
136.03%90.08M
Earning per share
Basic earning per share
4.93%0.1363
-13.33%0.13
14.29%0.16
33.33%0.16
53.91%0.1299
-16.67%0.15
-26.32%0.14
9.09%0.12
49.65%0.0844
135.29%0.18
Diluted earning per share
4.93%0.1363
-13.33%0.13
14.29%0.16
33.33%0.16
53.91%0.1299
-16.67%0.15
-26.32%0.14
9.09%0.12
49.65%0.0844
135.29%0.18
Other composite income
74.18%-194.65K
90.99%-753.76K
-917.56%-8.36M
Other composite income of parent company owners
----
76.27%-183.28K
----
----
----
90.44%-772.33K
----
----
----
-889.31%-8.08M
Other composite income of minority owners
----
-161.26%-11.37K
----
----
----
106.42%18.56K
----
----
----
---289.08K
Total composite income
5.84%69.46M
-23.36%63.49M
2.27%82.15M
16.05%79.59M
32.25%65.63M
-1.94%82.85M
-14.19%80.33M
29.15%68.58M
76.21%49.62M
132.25%84.49M
Total composite income of parent company owners
4.96%66.74M
-14.69%62.86M
11.16%78.88M
28.95%76.86M
53.94%63.58M
-10.15%73.68M
-22.49%70.96M
13.75%59.6M
49.61%41.3M
132.93%82M
Total composite income of minority owners
33.12%2.72M
-93.08%634.7K
-65.07%3.27M
-69.61%2.73M
-75.44%2.04M
269.09%9.17M
353.67%9.36M
1,177.32%8.98M
1,405.66%8.32M
119.13%2.48M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
ShinWing Certified Public Accountants (Special General Partnership)
--
--
--
ShinWing Certified Public Accountants (Special General Partnership)
--
--
--
ShinWing Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 17.04%488.22M12.11%1.37B18.71%1.06B18.14%779.28M21.48%417.14M-4.87%1.22B-7.93%893.53M-4.90%659.6M-11.13%343.38M13.56%1.28B
Operating revenue 17.04%488.22M12.11%1.37B18.71%1.06B18.14%779.28M21.48%417.14M-4.87%1.22B-7.93%893.53M-4.90%659.6M-11.13%343.38M13.56%1.28B
Other operating revenue ----25.40%1.52M----71.75%441.91K-----9.56%1.21M-----95.40%257.29K-----90.76%1.34M
Total operating cost 17.93%413.67M17.46%1.25B17.48%935.48M28.14%689.99M24.73%350.78M-8.77%1.06B-8.58%796.3M-13.79%538.46M-20.19%281.23M-12.22%1.16B
Operating cost 14.92%156.79M37.71%443.7M46.83%341.4M50.90%247.98M64.61%136.43M-7.26%322.2M-10.02%232.52M-12.21%164.34M-19.95%82.88M-5.39%347.42M
Operating tax surcharges 35.13%12.05M11.85%32.47M39.30%25.08M47.98%18.32M11.36%8.92M-8.33%29.03M-32.51%18.01M-41.87%12.38M15.17%8.01M54.12%31.67M
Operating expense 22.32%210.83M10.21%638.4M6.76%474.15M22.26%361.14M8.65%172.36M-9.97%579.28M-9.53%444.14M-16.03%295.39M-24.72%158.63M-18.84%643.46M
Administration expense 16.59%23.48M4.93%90.8M-8.42%62.67M-7.25%40.84M-0.22%20.14M-6.75%86.54M15.01%68.44M10.16%44.03M9.59%20.19M3.91%92.81M
Financial expense -33.87%397.13K-64.42%1.7M-78.50%1.14M-77.25%998.12K-76.36%600.56K-69.38%4.77M-52.40%5.28M-47.10%4.39M-36.20%2.54M-38.18%15.57M
-Interest expense (Financial expense) -23.22%541.89K-60.82%2.52M-73.16%1.79M-74.51%1.44M-69.85%705.75K-62.02%6.43M-40.00%6.67M-30.91%5.64M-41.72%2.34M-19.14%16.94M
-Interest Income (Financial expense) -22.46%-225.9K34.27%-1.16M41.44%-911.12K55.24%-587.8K75.28%-184.47K-16.78%-1.77M-76.08%-1.56M-345.83%-1.31M-485.93%-746.32K-56.69%-1.52M
Research and development -18.02%10.11M-0.33%38.47M11.22%31.04M15.50%20.72M37.31%12.34M22.98%38.59M14.26%27.91M11.99%17.94M2.41%8.98M8.36%31.38M
Credit Impairment Loss ----100.13%91.95K17.70%-12.97M76.13%-12.97M5,334.62%32.61K-179.90%-70.01M-102.55%-15.76M-597.51%-54.33M--600-4.75%-25.01M
Asset Impairment Loss -----104.68%-24.9M588,355.25%156.88K--156.88K-----288.29%-12.16M--26.66--------94.52%-3.13M
Other net revenue 270.28%339.83K80.58%-13.64M-267.70%-303.08K96.27%-1.5M-332.92%-199.57K-918.05%-70.22M97.40%-82.43K-1,057.11%-40.17M-84.74%85.68K91.39%-6.9M
Invest income 74.60%-93.46K70.75%-2.26M156.69%482.73K95.87%-40.76K57.83%-368.01K-632.31%-7.73M-844.57%-851.47K-1,002.28%-986.5K-2,759.47%-872.7K258.01%1.45M
-Including: Investment income associates ----77.40%-1.43M251.17%1.29M177.41%763.64K111.46%100K-536.69%-6.34M-844.57%-851.47K-1,002.28%-986.5K-2,759.47%-872.7K258.01%1.45M
Asset deal income ---------------------110.69%-21.47K-110.69%-21.47K--------1,128.13%200.89K
Other revenue 218.98%433.29K-31.86%13.43M-27.33%12.02M-25.04%11.35M-85.82%135.84K0.56%19.71M285.16%16.55M277.97%15.15M144.18%957.78K913.60%19.6M
Operating profit 13.20%74.89M21.28%110.12M28.61%124.94M8.43%87.79M6.31%66.16M-20.91%90.8M0.94%97.15M23.56%80.97M80.00%62.23M142.00%114.81M
Add:Non operating Income 1,474.38%23.7K-65.24%1.22M-89.89%61.17K649.87%58.66K275.01%1.51K1,976.20%3.51M-95.43%605.29K-92.46%7.82K-99.60%401.34-98.02%169.04K
Less:Non operating expense -70.54%30.61K-38.31%8.31M-14.65%6.93M-84.92%1.22M-98.72%103.92K-7.83%13.46M55.74%8.12M55.74%8.12M1,199.53%8.1M4,820.53%14.61M
Total profit 13.36%74.88M27.45%103.04M31.73%118.07M18.90%86.63M22.03%66.06M-19.45%80.85M-14.03%89.63M20.58%72.86M58.98%54.13M137.86%100.37M
Less:Income tax cost 1,164.34%5.42M1,528.80%39.35M286.03%35.91M64.65%7.04M-90.49%429.07K-136.61%-2.75M-12.63%9.3M-41.57%4.28M-23.43%4.51M453.69%7.52M
Add:Adjusted items effecting net profit ------------------------------0.01--------
Net profit 5.84%69.46M-23.82%63.69M2.27%82.15M16.05%79.59M32.25%65.63M-9.96%83.6M-14.19%80.33M29.15%68.58M76.21%49.62M135.30%92.85M
Net profit from continuing operation 5.84%69.46M-23.82%63.69M2.27%82.15M16.05%79.59M32.25%65.63M-9.96%83.6M-14.19%80.33M29.15%68.58M76.21%49.62M135.30%92.85M
Less:Minority Profit 33.12%2.72M-92.94%646.07K-65.07%3.27M-69.61%2.73M-75.44%2.04M229.94%9.15M353.67%9.36M1,177.32%8.98M1,405.66%8.32M121.35%2.77M
Net profit of parent company owners 4.96%66.74M-15.32%63.04M11.16%78.88M28.95%76.86M53.94%63.58M-17.35%74.45M-22.49%70.96M13.75%59.6M49.61%41.3M136.03%90.08M
Earning per share
Basic earning per share 4.93%0.1363-13.33%0.1314.29%0.1633.33%0.1653.91%0.1299-16.67%0.15-26.32%0.149.09%0.1249.65%0.0844135.29%0.18
Diluted earning per share 4.93%0.1363-13.33%0.1314.29%0.1633.33%0.1653.91%0.1299-16.67%0.15-26.32%0.149.09%0.1249.65%0.0844135.29%0.18
Other composite income 74.18%-194.65K90.99%-753.76K-917.56%-8.36M
Other composite income of parent company owners ----76.27%-183.28K------------90.44%-772.33K-------------889.31%-8.08M
Other composite income of minority owners -----161.26%-11.37K------------106.42%18.56K---------------289.08K
Total composite income 5.84%69.46M-23.36%63.49M2.27%82.15M16.05%79.59M32.25%65.63M-1.94%82.85M-14.19%80.33M29.15%68.58M76.21%49.62M132.25%84.49M
Total composite income of parent company owners 4.96%66.74M-14.69%62.86M11.16%78.88M28.95%76.86M53.94%63.58M-10.15%73.68M-22.49%70.96M13.75%59.6M49.61%41.3M132.93%82M
Total composite income of minority owners 33.12%2.72M-93.08%634.7K-65.07%3.27M-69.61%2.73M-75.44%2.04M269.09%9.17M353.67%9.36M1,177.32%8.98M1,405.66%8.32M119.13%2.48M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --ShinWing Certified Public Accountants (Special General Partnership)------ShinWing Certified Public Accountants (Special General Partnership)------ShinWing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More